Employees: 11 (2023.0)Legal category: 5785Size: PMECreation date: 2006-09-18 (19 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: SAINT-LOUIS (97450), La Reunion
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE BEL AIR : revenue, balance sheet and financial ratios
PHARMACIE BEL AIR is a French company
founded 19 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in SAINT-LOUIS (97450),
this company of category PME
shows in 2025 a net income positive of 46 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE BEL AIR (SIREN 491615498)
Indicator
2025
2024
2023
2021
2020
2018
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
46 317 €
104 760 €
124 340 €
179 615 €
103 649 €
103 765 €
130 813 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE BEL AIR generates positive net income of 46 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2025: 131 k€ -> 46 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
46 317 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 60%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 44%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
59.597%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
44.114%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2018
2020
2021
2023
2024
2025
Debt ratio
37.063
10.681
11.334
9.989
1.343
41.129
59.597
Financial autonomy
57.777
71.777
78.558
81.639
80.724
55.717
44.114
Repayment capacity
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
59.62025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Average+28 pts over 3 years
In 2025, the debt ratio of PHARMACIE BEL AIR (59.60) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
44.11%2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Average-37 pts over 3 years
In 2025, the financial autonomy of PHARMACIE BEL AIR (44.1%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 112.74. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
112.741
Liquidity indicators evolution PHARMACIE BEL AIR
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2018
2020
2021
2023
2024
2025
Liquidity ratio
117.695
110.297
209.482
307.253
189.625
132.614
112.741
Interest coverage
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
112.742025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Watch-28 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE BEL AIR (112.74) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Positioning of PHARMACIE BEL AIR in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE BEL AIR is estimated at
735 751 €
(range 499 284€ - 1 154 494€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
499k€735k€1154k€
735 751 €Range: 499 284€ - 1 154 494€
NAF 5 année 2025
Valuation method used
Net Income Multiple
46 317 €
×
15.9x
=735 751 €
Range: 499 284€ - 1 154 495€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE BEL AIR with other companies in the same sector:
Frequently asked questions about PHARMACIE BEL AIR
What is the revenue of PHARMACIE BEL AIR ?
The revenue of PHARMACIE BEL AIR is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE BEL AIR profitable?
Yes, PHARMACIE BEL AIR generated a net profit of 46 k€ in 2025.
Where is the headquarters of PHARMACIE BEL AIR ?
The headquarters of PHARMACIE BEL AIR is located in SAINT-LOUIS (97450), in the department La Reunion.
Where to find the tax return of PHARMACIE BEL AIR ?
The tax return of PHARMACIE BEL AIR is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE BEL AIR operate?
PHARMACIE BEL AIR operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart